Holen Sie sich die Stockscreener-App
2.54
3.79%
-0.10
Handel nachbörslich:
2.57
0.03
+1.18%
Schlusskurs vom Vortag:
$2.64
Offen:
$2.59
24-Stunden-Volumen:
25,103
Relative Volume:
0.32
Marktkapitalisierung:
$104.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.92M
KGV:
-8.4667
EPS:
-0.3
Netto-Cashflow:
$-7.05M
1W Leistung:
-5.93%
1M Leistung:
+9.96%
6M Leistung:
+120.87%
1J Leistung:
+38.04%
1-Tages-Spanne:
$2.54
$2.65
1-Wochen-Bereich:
$2.51
$2.7499
52-Wochen-Spanne:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Firmenname
Anebulo Pharmaceuticals Inc
Sektor
Branche
Telefon
737 203 5270
Adresse
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Vergleichen Sie ANEB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.54 | 108.46M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Anebulo Pharmaceuticals Inc Aktie (ANEB) Neueste Nachrichten
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowEarnings Performance Report & Reliable Breakout Forecasts - newser.com
Custom watchlist performance reports with Anebulo Pharmaceuticals Inc.Share Buyback & Precise Trade Entry Recommendations - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floorJuly 2025 Pullbacks & Capital Efficient Trade Techniques - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrendQuarterly Market Review & Fast Gain Swing Alerts - newser.com
Top chart patterns to watch in Anebulo Pharmaceuticals Inc.2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock resilient to inflationRate Cut & Real-Time Volume Analysis Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsQuarterly Trade Summary & Verified Short-Term Plans - newser.com
Advanced analytics toolkit walkthrough for Anebulo Pharmaceuticals Inc.July 2025 Market Mood & Fast Exit Strategy with Risk Control - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent movePortfolio Return Summary & Weekly High Return Stock Opportunities - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flowsWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutQuarterly Trade Summary & High Yield Stock Recommendations - newser.com
What Wall Street predicts for Anebulo Pharmaceuticals Inc. stock priceSell Signal & Weekly Return Optimization Alerts - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 yearsJuly 2025 EndofMonth & Growth Oriented Trading Recommendations - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.July 2025 Trends & Technical Analysis for Trade Confirmation - newser.com
Will earnings trigger a reversal in Anebulo Pharmaceuticals Inc.July 2025 Technicals & High Accuracy Trade Signal Alerts - newser.com
How Anebulo Pharmaceuticals Inc. stock reacts to global recession fearsJuly 2025 News Drivers & AI Based Buy/Sell Signal Reports - newser.com
Will Anebulo Pharmaceuticals Inc. stock attract ESG investorsJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimatesMarket Sentiment Summary & Reliable Price Action Trade Plans - newser.com
Finanzdaten der Anebulo Pharmaceuticals Inc-Aktie (ANEB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):